Drug intelligence / Profile preview

nerve growth factor 2.5S

Development stage
Unknown
Lead developer
Policlinico Gemelli
Modality
Recombinant Proteins and Enzymes
Administration
Ophthalmic
01

Overview

Nerve Growth Factor 2.5S (NGF 2.5S) is a purified murine-derived protein therapeutic isolated from mouse submaxillary glands. It represents the biologically active beta-subunit dimer of the NGF complex. As a member of the neurotrophin family, NGF 2.5S acts as a potent agonist for the high-affinity tropomyosin receptor kinase A (TrkA) and the low-affinity p75 neurotrophin receptor (p75NTR). In clinical research, particularly in Phase 2 trials conducted by the Policlinico Universitario Agostino Gemelli, it is being investigated as a neuroprotective ophthalmic solution for the treatment of retinitis pigmentosa (RP). The drug aims to mitigate inner retinal dysfunction and preserve photoreceptor activity. It is often studied in combination with other neuroprotective agents like coenzyme Q10.

Other names
murine nerve growth factormouse nerve growth factor2.5S nerve growth factorbeta-nerve growth factor
02

Targets

NTRK1 (Tropomyosin-related receptor kinase A)ITGA9 (Integrin alpha-9)NGFR (p75NTR)

Beyond the preview

Go deeper on nerve growth factor 2.5S.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on nerve growth factor 2.5S.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call